Susquehanna International Group, LLP Aclaris Therapeutics, Inc. Put Options Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

Put Options

20 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 May 07, 2024	SELL	$0.92 - $1.44 $5,888 - $9,216	-6,400 Reduced 28.96%	15,700 $19,000
Q4 2023 Feb 14, 2024	SELL	$0.64 - $6.49 $33,216 - $336,831	-51,900 Reduced 70.14%	22,100 $23,000
Q3 2023 Nov 14, 2023	SELL	$6.56 - $10.95 $225,008 - $375,585	-34,300 Reduced 31.67%	74,000 $506,000
Q2 2023 Aug 11, 2023	SELL	$7.89 - $10.64 $486,813 - $656,488	-61,700 Reduced 36.29%	108,300 $1.12 Million
Q1 2023 May 16, 2023	BUY	$7.07 - $17.95 $1.06 Million - $2.7 Million	150,300 Added 762.94%	170,000 $1.38 Million
Q4 2022 Feb 14, 2023	BUY	$14.33 - $18.37 $12,897 - $16,533	900 Added 4.79%	19,700 $310,000
Q3 2022 Nov 14, 2022	BUY	$13.07 - $18.22 $64,043 - $89,278	4,900 Added 35.25%	18,800 $296,000
Q2 2022 Aug 15, 2022	BUY	$10.16 - $17.08 $30,480 - $51,239	3,000 Added 27.52%	13,900 $194,000
Q1 2022 May 16, 2022	SELL	$9.74 - $17.92 $624,334 - $1.15 Million	-64,100 Reduced 85.47%	10,900 $188,000
Q2 2021 Aug 11, 2021	SELL	$17.08 - $29.6 $440,663 - $763,680	-25,800 Reduced 25.6%	75,000 $1.32 Million
Q1 2021 May 17, 2021	BUY	$5.86 - $27.73 $526,228 - $2.49 Million	89,800 Added 816.36%	100,800 $2.54 Million
Q4 2020 Feb 16, 2021	BUY	$2.65 - $7.61 $1,855 - $5,327	700 Added 6.8%	11,000 $71,000
Q3 2019 Nov 14, 2019	SELL	$0.79 - $2.47 $28,598 - $89,414	-36,200 Reduced 77.85%	10,300 $11,000
Q2 2019 Aug 14, 2019	BUY	$2.13 - $7.06 $2,130 - $7,060	1,000 Added 2.2%	46,500 $102,000
Q1 2019 May 15, 2019	BUY	$5.63 - $7.84 $256,165 - $356,720	45,500 New	45,500 $273,000
Q3 2018 Nov 14, 2018	SELL	$14.38 - $20.89 $258,840 - $376,020	-18,000 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$16.46 - $20.33 $57,610 - $71,155	3,500 Added 24.14%	18,000 $359,000
Q1 2018 May 15, 2018	SELL	$17.08 - $25.64 $783,971 - $1.18 Million	-45,900 Reduced 75.99%	14,500 $254,000
Q4 2017 Feb 14, 2018	BUY	$21.47 - $27.8 $1 Million - $1.3 Million	46,700 Added 340.88%	60,400 $1.49 Million
Q3 2017 Nov 14, 2017	BUY	$23.02 - $28.8 $315,374 - $394,560	13,700	13,700 $354,000

Others Institutions Holding ACRS

# of Institutions

Shares Held

50.7M

Call Options Held

30.6K

Put Options Held

Bml Capital Management, LLC Zionsville, IN

14.3M
Shares

$51.7 Million
9.64% of portfolio
Vanguard Group Inc Valley Forge, PA

4.69M
Shares

$17 Million
0.0% of portfolio
D. E. Shaw & Co., Inc. New York, NY

3.37M
Shares

$12.2 Million
0.0% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

3.01M
Shares

$10.9 Million
0.0% of portfolio
Rock Springs Capital Management LP Baltimore, MD

2.75M
Shares

$10 Million
0.11% of portfolio

View Full List

About Aclaris Therapeutics, Inc.

Ticker ACRS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 66,671,800
Market Cap $242M
Description
Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...

More about ACRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account